BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 8602705)

  • 21. Transitional cell carcinoma of the bladder associated with cyclophosphamide.
    Dale GA; Smith RB
    J Urol; 1974 Nov; 112(5):603-4. PubMed ID: 4214370
    [No Abstract]   [Full Text] [Related]  

  • 22. Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.
    Knight A; Askling J; Granath F; Sparen P; Ekbom A
    Ann Rheum Dis; 2004 Oct; 63(10):1307-11. PubMed ID: 15130900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary bladder tumors following cyclophosphamide therapy: a report of two cases with a review of the literature.
    Samra Y; Hertz M; Lindner A
    Med Pediatr Oncol; 1985; 13(2):86-91. PubMed ID: 3982369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperbaric oxygen therapy for Wegener's granulomatosis with cyclophosphamide-induced hemorrhagic cystitis.
    Kuroda I; Kuwata Y; Kakehi Y
    Int J Urol; 2002 Aug; 9(8):470-2. PubMed ID: 12225346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of cyclophosphamide treatment on the epithelium and stroma of the urinary bladder.
    Beyer-Boon ME; de Voogt HJ; Schaberg A
    Eur J Cancer (1965); 1978 Oct; 14(10):1029-35. PubMed ID: 710474
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cancer of the bladder after cystitis due to cyclophosphamide. Apropos of a case].
    Dore B; Grange P; Aubert J
    J Urol (Paris); 1989; 95(7):427-31. PubMed ID: 2687398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperbaric oxygen therapy for control of intractable cyclophosphamide-induced hemorrhagic cystitis.
    Shameem IA; Shimabukuro T; Shirataki S; Yamamoto N; Maekawa T; Naito K
    Eur Urol; 1992; 22(3):263-4. PubMed ID: 1468485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of mesna in preventing further cyclophosphamide-induced hemorrhagic cystitis.
    Luce JK; Simons JA
    Med Pediatr Oncol; 1988; 16(6):372-4. PubMed ID: 3143903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invasive bladder cancer after cyclophosphamide administration for nephrotic syndrome--a case report.
    Nakamoto T; Kasaoka Y; Ikegami Y; Usui T
    Hiroshima J Med Sci; 2000 Jun; 49(2):121-3. PubMed ID: 10920579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of Cyclophosphamide-induced Urotoxicity and Protective Effect of Mesna in Rheumatic Diseases.
    Yilmaz N; Emmungil H; Gucenmez S; Ozen G; Yildiz F; Balkarli A; Kimyon G; Coskun BN; Dogan I; Pamuk ON; Yasar S; Cetin GY; Yazici A; Ergulu Esmen S; Cagatay Y; Yilmaz S; Cefle A; Sayarlioglu M; Kasifoglu T; Karadag O; Pehlivan Y; Dalkilic E; Kisacik B; Cobankara V; Erken E; Direskeneli H; Aksu K; Yavuz S
    J Rheumatol; 2015 Sep; 42(9):1661-6. PubMed ID: 26178288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adriamycin enhancement of cyclophosphamide-induced bladder injury.
    Ershler WB; Gilchrist KW; Citrin DL
    J Urol; 1980 Jan; 123(1):121-2. PubMed ID: 7351704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urological complications of cyclophosphamide.
    Levine LA; Richie JP
    J Urol; 1989 May; 141(5):1063-9. PubMed ID: 2651710
    [No Abstract]   [Full Text] [Related]  

  • 33. [A case of pulmonary metastases from bladder cancer, suspected of recurrent Wegener's granulomatosis].
    Sekiya M; Ichikawa M; Tsutsui A; Yoshimi K; Suzuki T; Seyama K; Uekusa T; Takahashi K
    Nihon Kokyuki Gakkai Zasshi; 2009 Oct; 47(10):943-6. PubMed ID: 19882920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bladder cancer following administration of cyclophosphamide.
    Durkee C; Benson R
    Urology; 1980 Aug; 16(2):145-8. PubMed ID: 6250267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carcinoma of the bladder complicating cyclophosphamide therapy.
    Ansell ID; Castro JE
    Br J Urol; 1975 Aug; 47(4):413-8. PubMed ID: 1180990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclophosphamide hemorrhagic cystitis.
    Rubin JS; Rubin RT
    J Urol; 1966 Sep; 96(3):313-6. PubMed ID: 5953127
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of cyclophosphamide-induced hemorrhagic cystitis with intravesical carboprost tromethamine.
    Levine LA; Jarrard DF
    J Urol; 1993 Apr; 149(4):719-23. PubMed ID: 8455230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uroepithelial carcinoma in association with cyclophosphamide ingestion.
    Fuchs EF; Kay R; Poole R; Barry JM; Pearse HD
    J Urol; 1981 Oct; 126(4):544-5. PubMed ID: 7288948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclophosphamide-associated carcinoma of urothelium: modalities for prevention.
    Cannon J; Linke CA; Cos LR
    Urology; 1991 Nov; 38(5):413-6. PubMed ID: 1949449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Urothelial cancers from Endoxan].
    Dumas JP; Roulet B; Colombeau P; Loubet R
    J Urol (Paris); 1984; 90(6):411-2. PubMed ID: 6520414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.